Clinical-stage biopharmaceutical company GH Research PLC (NASDAQ: GHRS) announced positive results from recent clinical trials of its leading 5-MeO-DMT formula, a therapy candidate for patients suffering from treatment-resistant depression (TRD).
Besides being one of the most intimidating human beings ever to step into the boxing ring, former heavyweight champion Mike Tyson is also in the process of becoming a master at the art of dying.